Header Logo

Re: TP53INP1 as new therapeutic target in castration-resistant prostate cancer.

Atala A. Re: TP53INP1 as new therapeutic target in castration-resistant prostate cancer. J Urol. 2013 May; 189(5):1990-1.

View in: PubMed